# Coherus Oncology, Inc.: Form 8-K, filed Feb 4, 2026

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: 8-K
- Filed: 2026-02-04
- Accepted by EDGAR: Feb 4, 2026, 08:40 ET
- Period: 2026-02-04
- Accession: 0001104659-26-010065
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000110465926010065/chrs-20260204x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000110465926010065/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000110465926010065/chrs-20260204x8k.htm

Filed Feb 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-010065. Last ingested by Listed: Oct 29, 2026, 08:11 ET. No prices; not investment advice.